The estimated Net Worth of Daniel R Tereau is at least $4.8 Million dollars as of 20 March 2023. Mr. Tereau owns over 10,741 units of Revvity stock worth over $1,338,632 and over the last 9 years he sold PKI stock worth over $3,460,822. In addition, he makes $0 as Senior Vice President und Strategy and Business Development at Revvity.
Sign up
Mr. Tereau PKI stock SEC Form 4 insiders trading
Daniel has made over 15 trades of the Revvity stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 10,741 units of PKI stock worth $1,328,877 on 20 March 2023.
The largest trade he's ever made was selling 18,866 units of Revvity stock on 12 September 2016 worth over $981,032. On average, Daniel trades about 2,721 units every 90 days since 2016. As of 20 March 2023 he still owns at least 11,611 units of Revvity stock.
You can see the complete history of Mr. Tereau stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Daniel Tereau biography
Daniel R. Tereau JD. serves as Senior Vice President, Strategy and Business Development of the Company. He having joined PerkinElmer in April 2014 as Vice President, Strategy and Business Development. He is responsible for leading PerkinElmer’s overall strategic planning and business development activities. Prior to joining PerkinElmer, Mr. Tereau served on Novartis’ leadership team as Senior Vice President and Global Head of Strategy, Business Development and Licensing from 2011 to 2014, where he was responsible for global strategy and business development for the Consumer Health division. Prior to 2011, Mr. Tereau held similar roles at Thermo Fisher Scientific and GE Healthcare. Mr. Tereau holds a Bachelor of Science degree in finance from Ferris State University, a Juris Doctorate from Wayne State University, and earned his Master of Business Administration from Yale University.
How old is Daniel Tereau?
Daniel Tereau is 53, he's been the Senior Vice President und Strategy and Business Development of Revvity since 2016. There are 11 older and 9 younger executives at Revvity. The oldest executive at Revvity Inc. is Peter Barrett, 67, who is the Independent Director.
What's Daniel Tereau's mailing address?
Daniel's mailing address filed with the SEC is 940, Winter Street, Prospectville, Waltham, Middlesex County, Massachusetts, 02451, United States.
Insiders trading at Revvity
Over the last 26 years, insiders at Revvity have traded over $204,298,889 worth of Revvity stock and bought 55,200 units worth $1,110,570 . The most active insiders traders include Alexis P Michas, Gregory L Summe und Robert F Friel. On average, Revvity executives and independent directors trade stock every 25 days with the average trade being worth of $6,184,617. The most recent stock trade was executed by Andrew Okun on 13 April 2023, trading 2,435 units of PKI stock currently worth $332,402.
What does Revvity do?
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to serve the diagnostics, life sciences, food, and applied markets. IT strategically partners with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Its dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.
What does Revvity's logo look like?
Complete history of Mr. Tereau stock trades at Revvity
Revvity executives and stock owners
Revvity executives and other stock owners filed with the SEC include:
-
Dr. Prahlad R. Singh Ph.D.,
CEO, Pres & Director -
Prahlad Singh,
President, Chief Executive Officer, Director -
Joel Goldberg,
Senior Vice President - Administration, General Counsel, Secretary -
James M. Mock,
Sr. VP & CFO -
Joel S. Goldberg,
Sr. VP of Admin., Gen. Counsel & Sec. -
James Mock,
Chief Financial Officer, Senior Vice President -
Deborah Butters,
Chief Human Resource Officer, Senior Vice President -
Tajinder Vohra,
Sr. VP of Global Operations -
Alexandros Michas,
Independent Non-Executive Chairman of the Board -
Samuel Chapin,
Independent Director -
Peter Barrett,
Independent Director -
Pascale Witz,
Independent Director -
Frank Witney,
Independent Director -
Sylvie Gregoire,
Independent Director -
Michel Vounatsos,
Independent Director -
Andrew Okun,
Chief Accounting Officer, Vice President -
Tajinder Vohra,
Senior Vice President, Global Operations -
Daniel Tereau,
Senior Vice President, Strategy and Business Development -
Masoud Toloue,
Sr. VP of Diagnostics -
Miriame Victor,
Sr. VP & Chief Commercial Officer -
Robert Francis Friel,
Advisor -
Stephen Barr Willoughby,
VP of Investor Relations -
Andrew Okun,
VP, Chief Accounting Officer & Treasurer -
Michelle Mc Murry Heath,
Director -
Nicholas A Lopardo,
Director -
James Corbett,
See Remarks -
Alexis P Michas,
Director -
Vicki L Sato,
Director -
Kenton J Sicchitano,
Director -
Robert F Friel,
Chief Financial Officer -
Patrick J Sullivan,
Director -
Frank Anders Wilson,
SVP, CFO & CAO -
John A Roush,
Vice President -
Michael Louis Battles,
VP & Chief Accounting Officer -
Jeffrey D Capello,
Chief Accounting Officer -
Gregory L Summe,
Chairman & CEO -
Katherine A O Hara,
SVP & General Counsel -
Richard F Walsh,
Senior Vice President -
Tamara J Erickson,
Director -
Robert A Barrett,
Sr. Vice President -
Terrance L Carlson,
Sr. VP & General Counsel -
Peter B Coggins,
Sr. Vice President -
John Patrick Murphy,
Sr. Vice President -
John R Letcher,
Senior Vice President, HR -
Jonathan P. Di Vincenzo,
See Remarks -
James C Mullen,
Director -
Maurice H. Tenney,
See Remarks -
Daniel R Marshak,
SVP & CSO -
E Kevin Hrusovsky,
See Remarks -
G Robert Tod,
Director -
Gabriel Schmergel,
Director -
Miriame Victor,
Please See Remarks -
Maxwell Krakowiak,
Please See Remarks